Does the FDA review the safety of wrinkle fillers after they are on the market?
Yes, the FDA reviews the post-marketing experience of all dermal fillers. All adverse events not included in the product labeling must be reported to the FDA. Since the launch of ArteFill in February 2007, there have been no significant differences in the product’s safety profile as compared to the events reported during the clinical study.
